Both Ketamine and NBQX Attenuate Alcohol-Withdrawal Induced Depression in Male Rats
Journal of Drug and Alcohol Research 2018 DOI: 10.4303/jdar/236069 (opens in new tab)
Study at a glance
AI-extracted from the abstract| Characteristics | Preclinical animal study Peer reviewed |
|---|---|
| Population | Adult male Wistar rats exposed to ethanol via inhalation chambers |
| Interventions | Ketamine NBQX |
| Dose | Ketamine 2.5 mg/kg; NBQX 5 mg/kg |
| Duration | Ethanol exposure 4 h/day for 7 days; assessments 18 h after injections; sacrifice 2 h after behavioral tests |
| Measures | Open field locomotor activity (OFLA), forced swim test (FST), hippocampal brain-derived neurotrophic factor (BDNF) |
| Topics | Depression Esketamine Ketamine |
| Citations | 17 |
| Key points | Alcohol withdrawal increased immobility in the forced swim test and reduced hippocampal BDNF in rats. Ketamine (2.5 mg/kg) and NBQX (5 mg/kg) each normalized both the swimming score and hippocampal BDNF, but combining the two drugs cancelled each other's effects. The authors suggest NMDA or AMPA/kainate receptor antagonists, acting at least partially through hippocampal BDNF, may have therapeutic potential in alcohol use disorder. |
Abstract
The co-morbidity between heavy drinking and depression can negatively influence successful cessation of alcohol use. Since ketamine, a glutamatergic NMDA receptor antagonist, has shown promise as a quick-acting antidepressant, we studied its effects specifically on alcohol withdrawal-induced depression. We also evaluated the effects of NBQX an AMPA/kainate receptor antagonist, because some of the effects of ketamine are proposed to be indirectly mediated through these receptors. Adult male Wistar rats were exposed daily to ethanol via inhalation chambers 4 h/day for 7 days (blood alcohol concentration=160 mg%), followed by daily intraperitoneal injections of ketamine (2.5 mg/kg), NBQX (5mg/kg), alone or in combination. Eighteen hours later, open field locomotor activity (OFLA) followed by forced swim test (FST) were performed. The animals were sacrificed 2 h later for evaluation of brain-derived neurotrophic factor (BDNF) in the hippocampus. Alcohol withdrawal did not affect OFLA, but caused an increase in immobility in FST, suggesting induction of "depressive-like" helplessness. Both ketamine and NBQX normalized the swimming score in FST. The combination of the two drugs, however, cancelled each other's effect. Parallel to these behavioral observations, both ketamine and NBQX normalized the reduction in hippocampal BDNF caused by alcohol withdrawal. Here also, the combination of the two drugs cancelled each other's effect. These results suggest that either NMDA or AMPA/kainate receptor antagonists, acting at least partially through hippocampal BDNF, may be of therapeutic potential in alcohol use disorder.
Comparable studies
Other preclinical and animal studies on ketamine for depression, most cited first.
Citations in the library
Cited by 5
- Therapeutic potential of ketamine for alcohol use disorder. Neuroscience & Biobehavioral Reviews July 1, 2021
- Repeated Dosing of Ketamine in the Forced Swim Test: Are Multiple Shots Better Than One? Frontiers in Psychiatry May 11, 2021
- Epigenetic drugs and psychedelics as emerging therapies for alcohol use disorder: insights from preclinical studies. Journal of Neural Transmission May 1, 2024
- [Interest and mechanisms of action of ketamine in alcohol addiction- A review of clinical and preclinical studies]. Biologie aujourd'hui 2023
- Effect of ketamine enantiomers and maternal deprivation on depressive-like behavior and plasma concentration of BDNF in rats Research, Society and Development July 15, 2024
Cites 12
- A Randomized Trial of an N-methyl-D-aspartate Antagonist in Treatment-Resistant Major Depression Archives of General Psychiatry August 1, 2006
- NMDAR inhibition-independent antidepressant actions of ketamine metabolites Nature April 24, 2016
- Ketamine and rapid-acting antidepressants: a new era in the battle against depression and suicide F1000Research May 24, 2018
- Effect of Ketamine on LTP and NMDAR EPSC in Hippocampus of the Chronic Social Defeat Stress Mice Model of Depression Frontiers in Behavioral Neuroscience October 9, 2018
- No Sex-Specific Differences in the Acute Antidepressant Actions of (R)-Ketamine in an Inflammation Model The International Journal of Neuropsychopharmacology June 6, 2018
and 7 more in the library